相方 浩Hiroshi Aikata

Last Updated :2017/11/01

所属・職名
病院(医) 消化器診療科 講師
ホームページ
メールアドレス
aikatahiroshima-u.ac.jp
その他連絡先
広島市南区霞1-2-3
TEL:0822575555 FAX:0822575194

基本情報

学位

  • 博士(医学) (広島大学)

研究分野

  • 医歯薬学 / 内科系臨床医学 / 消化器内科学

研究キーワード

  • 肝疾患

教育活動

授業担当

  1. 2017年, 学部専門, 集中, 器官・システム病態制御学I
  2. 2017年, 学部専門, 集中, 症候診断治療学
  3. 2017年, 学部専門, 集中, 臨床実習・臨床実践学
  4. 2017年, 学部専門, 集中, アドバンスト医学実習
  5. 2017年, 修士課程・博士課程前期, セメスター(後期), 臨床医歯学総論
  6. 2017年, 博士課程・博士課程後期, セメスター(前期), がん診療各論

研究活動

学術論文(★は代表的な論文)

  1. Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers, NATURE GENETICS, 43巻, 8号, pp.797-pp.U108, AUG 2011
  2. Hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic interferon-a for advanced hepatocellular carcinoma in combination with or without three-dimensional conformal radiotherapy to venous tumor thrombosis in hepatic vein or inferior vena cava, HEPATOLOGY RESEARCH, 42巻, 5号, pp.442-pp.453, MAY 2012
  3. IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinoma, JOURNAL OF VIRAL HEPATITIS, 18巻, 10号, pp.E550-pp.E560, OCT 2011
  4. Clinical outcome of esophageal varices after hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with major portal vein tumor thrombus, HEPATOLOGY RESEARCH, 41巻, 11号, pp.1046-pp.1056, NOV 2011
  5. Impact of Pegylated Interferon Therapy on Outcomes of Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Hepatic Resection, ANNALS OF SURGICAL ONCOLOGY, 19巻, 2号, pp.418-pp.425, FEB 2012
  6. Recent trend of clinical features in patients with hepatocellular carcinoma, HEPATOLOGY RESEARCH, 42巻, 4号, pp.368-pp.375, APR 2012
  7. A huge metastatic liver tumor from leiomyosarcoma of the inferior vena cava: report of a case, SURGERY TODAY, 42巻, 5号, pp.505-pp.508, MAY 2012
  8. Hepatocellular carcinoma: Towards personalized medicine, CANCER SCIENCE, 103巻, 5号, pp.846-pp.850, MAY 2012
  9. Achievement of Sustained Viral Response after Switching Treatment from Pegylated Interferon alpha-2b to alpha-2a and Ribavirin in Patients with Recurrence of Hepatitis C Virus Genotype 1 Infection after Liver Transplantation: A Case Report, INTERVIROLOGY, 55巻, 4号, pp.306-pp.310, 2012
  10. Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B, JOURNAL OF MEDICAL VIROLOGY, 85巻, 5号, pp.789-pp.798, MAY 2013
  11. Genetics of IL28B and HCV-response to infection and treatment, NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 9巻, 7号, pp.406-pp.417, JUL 2012
  12. Severe necroinflammatory reaction caused by natural killer cell-mediated Fas/Fas ligand interaction and dendritic cells in human hepatocyte chimeric mouse, HEPATOLOGY, 56巻, 2号, pp.555-pp.566, AUG 2012
  13. Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 27巻, 9号, pp.1467-pp.1472, SEP 2012
  14. Evaluation of the mRECIST and alpha-Fetoprotein Ratio for Stratification of the Prognosis of Advanced-Hepatocellular-Carcinoma Patients Treated with Sorafenib, ONCOLOGY, 83巻, 4号, pp.192-pp.200, 2012
  15. Hepatitis B Virus-Specific miRNAs and Argonaute2 Play a Role in the Viral Life Cycle, PLOS ONE, 7巻, 10号, OCT 16 2012
  16. Efficacy of rosuvastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study, HEPATOLOGY RESEARCH, 42巻, 11号, pp.1065-pp.1072, NOV 2012
  17. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma according to Child-Pugh classification, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 27巻, 12号, pp.1850-pp.1857, DEC 2012
  18. Surgical treatment for portosystemic encephalopathy in patients with liver cirrhosis: Occlusion of portosystemic shunt in combination with splenectomy, HEPATOLOGY RESEARCH, 43巻, 3号, pp.249-pp.254, MAR 2013
  19. Surgical treatment for portosystemic encephalopathy in patients with liver cirrhosis: Occlusion of portosystemic shunt in combination with splenectomy, HEPATOLOGY RESEARCH, 43巻, 3号, pp.249-pp.254, MAR 2013
  20. Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 28巻, 3号, pp.530-pp.536, MAR 2013
  21. Airway Stenting for Tracheal Obstruction Due to Lymph Node Metastasis of Hepatocellular Carcinoma, ANTICANCER RESEARCH, 33巻, 4号, pp.1761-pp.1764, APR 2013
  22. Small Bowel Abnormalities in Patients with Compensated Liver Cirrhosis, DIGESTIVE DISEASES AND SCIENCES, 58巻, 5号, pp.1390-pp.1396, MAY 2013
  23. Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric mice, GUT, 62巻, 7号, pp.1055-pp.1061, JUL 2013
  24. Dynamic computed tomography appearance of tumor response after stereotactic body radiation therapy for hepatocellular carcinoma: How should we evaluate treatment effects?, HEPATOLOGY RESEARCH, 43巻, 7号, pp.717-pp.727, JUL 2013
  25. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 441巻, 1号, pp.230-pp.235, NOV 8 2013
  26. Risk factors for the exacerbation of esophageal varices or portosystemic encephalopathy after sustained virological response with IFN therapy for HCV-related compensated cirrhosis, JOURNAL OF GASTROENTEROLOGY, 48巻, 7号, pp.847-pp.855, JUL 2013
  27. Risk factors for the exacerbation of esophageal varices or portosystemic encephalopathy after sustained virological response with IFN therapy for HCV-related compensated cirrhosis, JOURNAL OF GASTROENTEROLOGY, 48巻, 7号, pp.847-pp.855, JUL 2013
  28. Inferior vena cava tumor thrombus that directly infiltrated from paracaval lymph node metastases in a patient with recurrent hepatocellular carcinoma, WORLD JOURNAL OF SURGICAL ONCOLOGY, 11巻, AUG 6 2013
  29. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice, JOURNAL OF GASTROENTEROLOGY, 48巻, 11号, pp.1259-pp.1270, NOV 2013
  30. Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 28巻, 12号, pp.1834-pp.1841, DEC 2013
  31. Hypovascular Hepatic Nodules Showing Hypointense on the Hepatobiliary-Phase Image of Gd-EOB-DTPA-Enhanced MRI to Develop a Hypervascular Hepatocellular Carcinoma: A Nationwide Retrospective Study on Their Natural Course and Risk Factors, DIGESTIVE DISEASES, 31巻, 5-6号, pp.472-pp.479, 2013
  32. HLA-DQB1*03 Confers Susceptibility to Chronic Hepatitis C in Japanese: A Genome-Wide Association Study, PLOS ONE, 8巻, 12号, DEC 20 2013
  33. Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases, HEPATOLOGY RESEARCH, 43巻, 11号, pp.1182-pp.1189, NOV 2013
  34. Is small-bowel capsule endoscopy effective for diagnosis of esophagogastric lesions related to portal hypertension?, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 29巻, 3号, pp.511-pp.516, MAR 2014
  35. Non-invasive liver fibrosis score calculated by combination of virtual touch tissue quantification and serum liver functional tests in chronic hepatitis C patients, HEPATOLOGY RESEARCH, 44巻, 3号, pp.280-pp.287, MAR 2014
  36. Expression of telomerase component genes in hepatocellular carcinomas., Eur. J. Cancer, 36巻, pp.496-pp.502, 20000401
  37. Precancerous hepatic nodules had significant levels of telomerase activity by sensitive quantitation using hybridization protection assay., Cancer, 88巻, pp.312-pp.317, 20000401
  38. Telomere reduction in human liver tissues with age and chronic inflammation., Exp Cell Res, 256巻, pp.578-pp.582, 20000401
  39. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma : Comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion, Journal of Vascular and Interventional Radiology, 12巻, 7号, pp.847-pp.854, 20010701
  40. Expression of telomerase component genes in hepatocellular carcinomas, European Journal of Cancer, 36巻, 4号, pp.496-pp.502, 20000401
  41. A quantitative method to measure telomerase activity by hybridization protectin assay (HPA) connected with TRAP for the diagnosis of hepatocellular carcinoma (HCC)., Gastroenterology, 114巻, 4号, pp.A1351-A1351, 19980401
  42. Telomeres and telomerase in hepatocellular carcinoma., Recent Res. Devel. Cancer, 6巻, pp.191-pp.210, 20040401
  43. Should splenectomy be performed for hepatitis C patients undergoing living-donor liver transplantation?, J Gastroenterol Hepatol, 22巻, 6号, pp.959-pp.960, 20070201
  44. A Case of Fulminant Hepatic Failure Caused by Hepatitis E virus79117, Clinical Journal of gastroenterology, 1巻, pp.69-pp.74, 20080603
  45. Combination therapy of oral fluoropyrimidine anticancer drug S-1 and interferon alpha for HCC patients with extrahepatic metastases, 20080822
  46. Clinicopathological features of elderly patients with hepatitis C virus-related hepatocellular carcinoma., 20080723
  47. Evaluation of patients with esophageal varices after endoscopic injection sclerotherapy using multiplanar reconstruction MDCT images., 20090101
  48. Successful treatment of pulmonary metastases associated with advanced hepatocellular carcinoma by systemic 5-fluorouracil combined with interferon-alpha in a hemodialysis patient., 20090401
  49. The first Japanese case of COACH syndrome., Hepatol Res., 20090301
  50. Evaluation of portosystemic collaterals by MDCT-MPR imaging for management of hemorrhagic esophageal varices., Eur J Radiol., 20090701
  51. Amino acid substitutions in core and NS5A regions of the HCV genome can predict virological decrease with pegylated interferon plus ribavirin therapy., Antivir Ther, 15巻, 8号, pp.1087-pp.1097, 20101201
  52. Clinical features and prognosis inpatients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy., 20110801
  53. Recent trend of clinical features in patients with hepatocellular carcinoma, 20110701
  54. Cutaneous complications after transcatheter arterial treatment for hepatocellular carcinoma via the internal mammary artery:how to avoid this complication.Kajiwara K, Kakizawa H,Awai K,et al.Jpn J Radiol,29(5)307-315,2011, 29巻, 5号, pp.307-pp.315, 20110601
  55. Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma., Am J Surg., 184巻, 3号, pp.284-pp.290, 20020901
  56. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage., AJR Am J Roentgenol., 178巻, 5号, pp.1167-pp.1174, 20020501
  57. Impact of aging on the development of hepatocellular carcinoma in patients with hepatitis C virus infection in Japan., Scand J Gastroenterol., 38巻, 8号, pp.894-pp.900, 20030801
  58. The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration., J Gastroenterol., 42巻, 8号, pp.663-pp.672, 20070801
  59. Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma., World J Gastroenterol., 13巻, 39号, pp.5188-pp.5195, 20071001
  60. Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma., World J Gastroenterol., 13巻, 40号, pp.5343-pp.5350, 20070901
  61. Balloon-occluded retrograde transvenous obliteration for portal-systemic encephalopathy due to superior mesenteric-caval shunt via the right gonadal vein., Intern Med., 46巻, 17号, pp.1479-pp.1480, 20070901
  62. Efficacy of percutaneous cementoplasty for bone metastasis from hepatocellular carcinoma., Oncology., 72巻, 5-6号, pp.285-pp.292, 20070101
  63. Eicosapentaenoic acid could permit maintenance of the original ribavirin dose in chronic hepatitis C virus patients during the first 12 weeks of combination therapy with pegylated interferon-alpha and ribavirin. A prospective randomized controlled trial., Intervirology., 50巻, 6号, pp.439-pp.446, 20080201
  64. Similar effects of recombinant interferon-alpha-2b and natural interferon-alpha when combined with intra-arterial 5-fluorouracil for the treatment of advanced hepatocellular, Liver International., 27巻, 9号, pp.1209-pp.1216, 20071101
  65. Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma., J Gastroenterol., 42巻, 10号, pp.845-pp.853, 20071001
  66. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma., World J Gastroenterol., 13巻, 3号, pp.414-pp.420, 20070101
  67. Etiology and outcome of acute liver failure: retrospective analysis of 50 patients treated at a single center., J Gastroenterol Hepatol., 23巻, 8pt1号, pp.1216-pp.1222, 20080801
  68. Prospective study of short-term peginterferon-alpha-2a monotherapy in patients who had a virological response at 2 weeks after initiation of interferon therapy., J Gastroenterol Hepatol., 23巻, 4号, pp.541-pp.545, 20080401
  69. Beneficial effects of living-donor liver transplantation on esophageal varices., J Gastroenterol., 43巻, 12号, pp.982-pp.989, 20081201
  70. Systemic gemcitabine combined with intra-arterial low-dose cisplatin and 5-fluorouracil for advanced hepatocellular carcinoma: seven cases., World J Gastroenterol., 14巻, 16号, pp.2602-pp.2608, 20080401
  71. Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis., J Gastroenterol., 44巻, 5号, pp.492-pp.502, 20090301
  72. Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma., Cardiovasc Intervent Radiol., 32巻, 4号, pp.687-pp.694, 20090701
  73. FDG positron emission tomography/computed tomography for the detection of extrahepatic metastases from hepatocellular carcinoma., Hepatol Res., 39巻, 2号, pp.134-pp.142, 20090201
  74. Dose comparison study of pegylated interferon-alpha-2b plus ribavirin in naive Japanese patients with hepatitis C virus genotype 2: a randomized clinical trial., J Gastroenterol Hepatol., 24巻, 3号, pp.366-pp.371, 20090301
  75. Randomized trial of high-dose interferon-alpha-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy., J Med Virol., 81巻, 4号, pp.640-pp.649, 20090401
  76. Pilot study of systemic combination therapy with S-1, an oral fluoropyrimidine, and cisplatin for hepatocellular carcinoma with extrahepatic metastases., Hepatogastroenterology., 57巻, 102-103号, pp.1272-pp.1278, 20100901
  77. Zoledronic acid delays disease progression of bone metastases from hepatocellular carcinoma., Hepatol Res., 40巻, 12号, pp.1195-pp.1203, 20101201
  78. Intra-arterial 5-fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases., J Gastroenterol Hepatol., 25巻, 6号, pp.1117-pp.1122, 20100601
  79. Hypersensitivity reactions to transcatheter chemoembolization with cisplatin and Lipiodol suspension for unresectable hepatocellular carcinoma., J Vasc Interv Radiol., 21巻, 8号, pp.1219-pp.1225, 20100801
  80. Transcatheter chemoembolization for unresectable hepatocellular carcinoma and comparison of five staging systems., Hepatol Res., 40巻, 11号, pp.1082-pp.1091, 20101101
  81. Prolongation of interferon therapy for recurrent hepatitis C after living donor liver transplantation: analysis of predictive factors of sustained virological response, including amino acid sequence of the core and NS5A regions of hepatitis C virus., Scand J Gastroenterol., 45巻, 12号, pp.1488-pp.1496, 20101201
  82. Evaluation of portosystemic collaterals by MDCT-MPR imaging for management of hemorrhagic esophageal varices., Eur J Radiol., 76巻, 2号, pp.239-pp.245, 20101101
  83. Importance of serum concentration of adefovir for Lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B., Antimicrob Agents Chemother., 54巻, 8号, pp.3205-pp.3211, 20100801
  84. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up., J Gastroenterol Hepatol., 25巻, 3号, pp.597-pp.604, 20100301
  85. Eradication of hepatitis C virus genotype 1 after liver transplantation by interferon therapy before surgery: Report of three patients with analysis of interleukin-28 polymorphism, hepatitis C virus core region and interferon-sensitivity determining region., Hepatol Res., 41巻, 11号, pp.1126-pp.1131, 20111101
  86. IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinoma., J Viral Hepat., 18巻, 10号, pp.e550-560, 20111001
  87. ★, Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers., Nat Genet., 43巻, 8号, pp.797-pp.800, 20110801
  88. Treatment strategy for early hepatocellular carcinomas: comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection., J Surg Oncol., 104巻, 1号, pp.41342, 20110701
  89. Percutaneous Transvenous Embolization for Portal-Systemic Shunts associated with Encephalopathy: Long-term outcomes in 14 patients., Hepatol Res., 20130601
  90. Migration to the pulmonary artery of nine metallic coils placed in the internal iliac vein for treatment of giant rectal varices., Acta Radiol, 1巻, 6号, 20120601
  91. Long-Term Outcomes of Hepatic Arterial Port Implantation using a Coaxial Microcatheter System in 176 Patients with Hepatocellilar Carcinoma., J Med Sci, 61巻, 1号, pp.7-pp.13, 20120301
  92. Case Reports of Portal Vein Thrombosis and Bile Duct Stenosis after Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma., Hepatol Res., 20130901
  93. Two patients treated with PEGIFN/RBV/TVR triple therapy for recurrent hepatitis C after living donor liver transplantation, Hepatol Res, 20140101
  94. The long-term outcome of patients with gastric varices treated by balloon-occluded retrograde transvenous obliteration, J Gastroenterol Hepatol, 20131201
  95. Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C, J Gastroenterol, 20131201
  96. Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients., J Gastroenterol, 20131101
  97. Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridization protection assay, CANCER, 88巻, 2号, pp.312-pp.317, JAN 15 2000
  98. Expression of telomerase component genes in hepatocellular carcinomas, EUROPEAN JOURNAL OF CANCER, 36巻, 4号, pp.496-pp.502, MAR 2000
  99. Telomere reduction in human liver tissues with age and chronic inflammation, EXPERIMENTAL CELL RESEARCH, 256巻, 2号, pp.578-pp.582, MAY 1 2000
  100. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: Comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion, JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 12巻, 7号, pp.847-pp.854, JUL 2001
  101. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage, AMERICAN JOURNAL OF ROENTGENOLOGY, 178巻, 5号, pp.1167-pp.1174, MAY 2002
  102. Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma, AMERICAN JOURNAL OF SURGERY, 184巻, 3号, pp.284-pp.290, SEP 2002
  103. Impact of aging on the development of hepatocellular carcinoma in patients with hepatitis C virus infection in Japan, SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 38巻, 8号, pp.894-pp.900, AUG 2003
  104. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma, WORLD JOURNAL OF GASTROENTEROLOGY, 13巻, 3号, pp.414-pp.420, JAN 21 2007
  105. The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration, JOURNAL OF GASTROENTEROLOGY, 42巻, 8号, pp.663-pp.672, AUG 2007
  106. Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma, WORLD JOURNAL OF GASTROENTEROLOGY, 13巻, 39号, pp.5188-pp.5195, OCT 21 2007
  107. Effects of a 24-week course of interferon-a therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma, WORLD JOURNAL OF GASTROENTEROLOGY, 13巻, 40号, pp.5343-pp.5350, OCT 28 2007
  108. Similar effects of recombinant interferon-alpha-2b and natural interferon-alpha when combined with intra-arterial 5-fluorouracil for the treatment of advanced hepatocellular carcinoma, LIVER INTERNATIONAL, 27巻, 9号, pp.1209-pp.1216, NOV 2007
  109. Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma, JOURNAL OF GASTROENTEROLOGY, 42巻, 10号, pp.845-pp.853, OCT 2007
  110. Efficacy of percutaneous cementoplasty for bone metastasis from hepatocellular carcinoma, ONCOLOGY, 72巻, 5-6号, pp.285-pp.292, 2007
  111. Systemic gemcitabine combined with intra-arterial low-dose cisplatin and 5-fluorouracil for advanced hepatocellular carcinoma: Seven cases, WORLD JOURNAL OF GASTROENTEROLOGY, 14巻, 16号, pp.2602-pp.2608, APR 28 2008
  112. Eicosapentaenoic acid could permit maintenance of the original ribavirin dose in chronic hepatitis C virus patients during the first 12 weeks of combination therapy with pegylated interferon-alpha and ribavirin, INTERVIROLOGY, 50巻, 6号, pp.439-pp.446, 2007
  113. Prospective study of short-term peginterferon-alpha-2a monotherapy in patients who had a virological response at 2 weeks after initiation of interferon therapy, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 23巻, 4号, pp.541-pp.545, APR 2008
  114. Etiology and outcome of acute liver failure: Retrospective analysis of 50 patients treated at a single center, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 23巻, 8号, pp.1216-pp.1222, AUG 2008
  115. Clinicopathological features of elderly patients with hepatitis C virus-related hepatocellular carcinoma, JOURNAL OF GASTROENTEROLOGY, 43巻, 7号, pp.550-pp.557, JUL 2008
  116. Balloon-occluded retrograde transvenous obliteration for portal-systemic encephalopathy due to superior mesenteric-caval shunt via the right gonadal vein, INTERNAL MEDICINE, 46巻, 17号, pp.1479-pp.1480, 2007
  117. Combination therapy of oral fluoropyrimidine anticancer drug S-1 and interferon alpha for HCC patients with extrahepatic metastases, ONCOLOGY, 75巻, 1-2号, pp.8-pp.16, 2008
  118. Evaluation of Patients with Esophageal Varices After Endoscopic Injection Sclerotherapy Using Multiplanar Reconstruction MDCT Images, AMERICAN JOURNAL OF ROENTGENOLOGY, 192巻, 1号, pp.122-pp.130, JAN 2009
  119. Beneficial effects of living-donor liver transplantation on esophageal varices, JOURNAL OF GASTROENTEROLOGY, 43巻, 12号, pp.982-pp.989, DEC 2008
  120. FDG positron emission tomography/computed tomography for the detection of extrahepatic metastases from hepatocellular carcinoma, HEPATOLOGY RESEARCH, 39巻, 2号, pp.134-pp.142, FEB 2009
  121. The first Japanese case of COACH syndrome, HEPATOLOGY RESEARCH, 39巻, 3号, pp.318-pp.323, MAR 2009
  122. Randomized Trial of High-Dose Interferon-alpha-2b Combined With Ribavirin in Patients With Chronic Hepatitis C: Correlation Between Amino Acid Substitutions in the Core/NS5A Region and Virological Response to Interferon Therapy, JOURNAL OF MEDICAL VIROLOGY, 81巻, 4号, pp.640-pp.649, APR 2009
  123. Dose comparison study of pegylated interferon-alpha-2b plus ribavirin in naive Japanese patients with hepatitis C virus genotype 2: A randomized clinical trial, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24巻, 3号, pp.366-pp.371, MAR 2009
  124. Successful treatment of pulmonary metastases associated with advanced hepatocellular carcinoma by systemic 5-fluorouracil combined with interferon-alpha in a hemodialysis patient, HEPATOLOGY RESEARCH, 39巻, 4号, pp.415-pp.420, APR 2009
  125. Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis, JOURNAL OF GASTROENTEROLOGY, 44巻, 5号, pp.492-pp.502, MAY 2009
  126. Transarterial Infusion Chemotherapy Using Cisplatin-Lipiodol Suspension With or Without Embolization for Unresectable Hepatocellular Carcinoma, CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 32巻, 4号, pp.687-pp.694, JUL 2009
  127. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: Results and prognostic factors on long-term follow up, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 25巻, 3号, pp.597-pp.604, MAR 2010
  128. Intra-arterial 5-fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 25巻, 6号, pp.1117-pp.1122, JUN 2010
  129. Importance of Serum Concentration of Adefovir for Lamivudine-Adefovir Combination Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B, ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 54巻, 8号, pp.3205-pp.3211, AUG 2010
  130. Hypersensitivity Reactions to Transcatheter Chemoembolization with Cisplatin and Lipiodol Suspension for Unresectable Hepatocellular Carcinoma, JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 21巻, 8号, pp.1219-pp.1225, AUG 2010
  131. Transcatheter chemoembolization for unresectable hepatocellular carcinoma and comparison of five staging systems, HEPATOLOGY RESEARCH, 40巻, 11号, pp.1082-pp.1091, NOV 2010
  132. Evaluation of portosystemic collaterals by MDCT-MPR imaging for management of hemorrhagic esophageal varices, EUROPEAN JOURNAL OF RADIOLOGY, 76巻, 2号, pp.239-pp.245, NOV 2010
  133. Prolongation of interferon therapy for recurrent hepatitis C after living donor liver transplantation: Analysis of predictive factors of sustained virological response, including amino acid sequence of the core and NS5A regions of hepatitis C virus, SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 45巻, 12号, pp.1488-pp.1496, DEC 2010
  134. Zoledronic acid delays disease progression of bone metastases from hepatocellular carcinoma, HEPATOLOGY RESEARCH, 40巻, 12号, pp.1195-pp.1203, DEC 2010
  135. Pilot Study of Systemic Combination Therapy with S-1, an Oral Fluoropyrimidine, and Cisplatin for Hepatocellular Carcinoma with Extrahepatic Metastases, HEPATO-GASTROENTEROLOGY, 57巻, 102-03号, pp.1272-pp.1278, SEP-OCT 2010
  136. Amino acid substitutions in core and NS5A regions of the HCV genome can predict virological decrease with pegylated interferon plus ribavirin therapy, ANTIVIRAL THERAPY, 15巻, 8号, pp.1087-pp.1097, 2010
  137. Treatment Strategy for Early Hepatocellular Carcinomas: Comparison of Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization and Surgical Resection, JOURNAL OF SURGICAL ONCOLOGY, 104巻, 1号, pp.3-pp.9, JUL 1 2011
  138. Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy, JOURNAL OF GASTROENTEROLOGY, 46巻, 6号, pp.799-pp.808, JUN 2011
  139. Cutaneous complications after transcatheter arterial treatment for hepatocellular carcinoma via the internal mammary artery: how to avoid this complication, JAPANESE JOURNAL OF RADIOLOGY, 29巻, 5号, pp.307-pp.315, JUN 2011
  140. Eradication of hepatitis C virus genotype 1 after liver transplantation by interferon therapy before surgery: Report of three patients with analysis of interleukin-28 polymorphism, hepatitis C virus core region and interferon-sensitivity determining region, HEPATOLOGY RESEARCH, 41巻, 11号, pp.1126-pp.1131, NOV 2011
  141. Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16 346 treated nodules in 13 283 patients, HEPATOLOGY RESEARCH, 42巻, 11号, pp.1058-pp.1064, NOV 2012
  142. Transarterial Therapy of Hepatocellular Carcinoma Fed by the Right Renal Capsular Artery, JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 25巻, 3号, pp.389-pp.395, MAR 2014
  143. Ultradeep Sequencing Study of Chronic Hepatitis C Virus Genotype 1 Infection in Patients Treated with Daclatasvir, Peginterferon, and Ribavirin, ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 58巻, 4号, pp.2105-pp.2112, APR 2014
  144. Long-term outcome of patients with gastric varices treated by balloon-occluded retrograde transvenous obliteration, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 29巻, 5号, pp.1035-pp.1042, MAY 2014
  145. Pilot Study of Stereotactic Body Radiation Therapy Combined with Transcatheter Arterial Chemoembolization for Small Hepatocellular Carcinoma, HEPATO-GASTROENTEROLOGY, 61巻, 129号, pp.31-pp.36, JAN-FEB 2014
  146. Efficacy and Safety of Sitagliptin for the Treatment of Nonalcoholic Fatty Liver Disease with Type 2 Diabetes Mellitus, HEPATO-GASTROENTEROLOGY, 61巻, 130号, pp.323-pp.328, MAR-APR 2014
  147. Percutaneous transvenous embolization for portosystemic shunts associated with encephalopathy: Long-term outcomes in 14 patients, HEPATOLOGY RESEARCH, 44巻, 7号, pp.740-pp.749, JUL 2014
  148. Transcatheter arterial chemoembolization with an interventional-CT system for recurrent hepatocellular carcinoma after living donor liver transplantation, HEPATO-GASTROENTEROLOGY, 61巻, 133号, pp.1387-pp.1392, JUL-AUG 2014
  149. Case reports of portal vein thrombosis and bile duct stenosis after stereotactic body radiation therapy for hepatocellular carcinoma, HEPATOLOGY RESEARCH, 44巻, 10号, pp.E273-pp.E278, OCT 2014
  150. Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation, HEPATOLOGY RESEARCH, 44巻, 12号, pp.1259-pp.1264, NOV 2014
  151. Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients, JOURNAL OF GASTROENTEROLOGY, 49巻, 11号, pp.1477-pp.1484, NOV 2014
  152. Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C, JOURNAL OF GASTROENTEROLOGY, 49巻, 12号, pp.1548-pp.1556, DEC 2014
  153. Differences in serum microRNA profiles in hepatitis B and C virus infection, JOURNAL OF INFECTION, 70巻, 3号, pp.273-pp.287, MAR 2015
  154. Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity, Nature Communications, 6巻, JAN 2015
  155. Clinical outcome and prognostic factors of patients with hepatocellular carcinoma and extrahepatic metastasis treated with sorafenib, HEPATOLOGY RESEARCH, 44巻, 13号, pp.1320-pp.1328, DEC 2014
  156. Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease, HEPATOLOGY RESEARCH, 44巻, 14号, pp.E420-pp.E427, DEC 2014
  157. Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C, HEPATOLOGY RESEARCH, 44巻, 14号, pp.E447-pp.E454, DEC 2014
  158. Major predictors of portal hypertensive enteropathy in patients with liver cirrhosis, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30巻, 1号, pp.124-pp.130, JAN 2015
  159. The effects of bisphosphonate zoledronic acid in hepatocellular carcinoma, depending on mevalonate pathway, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30巻, 3号, pp.619-pp.627, MAR 2015
  160. Evaluation of early response to hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma using the combination of Response Evaluation Criteria in Solid Tumors and tumor markers, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30巻, 4号, pp.726-pp.732, APR 2015
  161. Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1, JOURNAL OF VIRAL HEPATITIS, 22巻, 2号, pp.158-pp.165, FEB 2015
  162. Quantitative Effect of Natural Killer-Cell Licensing on Hepatocellular Carcinoma Recurrence after Curative Hepatectomy, CANCER IMMUNOLOGY RESEARCH, 2巻, 12号, pp.1142-pp.1147, DEC 2014
  163. Integrated Analysis of Whole Genome and Transcriptome Sequencing Reveals Diverse Transcriptomic Aberrations Driven by Somatic Genomic Changes in Liver Cancers, PLOS ONE, 9巻, 12号, DEC 19 2014
  164. Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies, HEPATOLOGY RESEARCH, 45巻, 4号, pp.378-pp.386, APR 2015
  165. Eicosapentaenoic acid/arachidonic acid ratio as a possible link between non-alcoholic fatty liver disease and cardiovascular disease, HEPATOLOGY RESEARCH, 45巻, 5号, pp.533-pp.539, MAY 2015
  166. Two Patients Treated With Simeprevir Plus Pegylated-Interferon and Ribavirin Triple Therapy for Recurrent Hepatitis C After Living Donor Liver Transplantation: Case Report, TRANSPLANTATION PROCEEDINGS, 47巻, 3号, pp.809-pp.814, APR 2015
  167. Role of 3-D conformal radiotherapy for major portal vein tumor thrombosis combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma, HEPATOLOGY RESEARCH, 45巻, 6号, pp.607-pp.617, JUN 2015
  168. Disseminated carcinomatosis of the bone marrow originating from hepatocellular carcinoma. A case report, HEPATOLOGY RESEARCH, 45巻, 6号, pp.705-pp.710, JUN 2015
  169. Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis, HEPATOLOGY RESEARCH, 45巻, 6号, pp.656-pp.662, JUN 2015
  170. The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma, PLOS ONE, 10巻, 6号, JUN 11 2015
  171. Efficacy of radiofrequency ablation for initial recurrent hepatocellular carcinoma after curative treatment: Comparison with primary cases, EUROPEAN JOURNAL OF RADIOLOGY, 84巻, 8号, pp.1540-pp.1545, AUG 2015
  172. Rapid, Sensitive, and Accurate Evaluation of Drug Resistant Mutant (NS5A-Y93H) Strain Frequency in Genotype 1b HCV by Invader Assay, PLOS ONE, 10巻, 6号, JUN 17 2015
  173. Association between variants in the interferon lambda 4 locus and substitutions in the hepatitis C virus non-structural protein 5A, JOURNAL OF HEPATOLOGY, 63巻, 3号, pp.554-pp.563, SEP 2015
  174. Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG Mice, JOURNAL OF VIROLOGY, 89巻, 19号, pp.10087-pp.10096, OCT 2015
  175. Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapy, JOURNAL OF MEDICAL VIROLOGY, 87巻, 11号, pp.1913-pp.1920, NOV 2015
  176. Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma, JOURNAL OF DIGESTIVE DISEASES, 16巻, 9号, pp.505-pp.512, SEP 2015
  177. Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma, EUROPEAN RADIOLOGY, 25巻, 11号, pp.3272-pp.3281, NOV 2015
  178. Clinical utility of gadoxetate disodium-enhanced hepatic MRI for stereotactic body radiotherapy of hepatocellular carcinoma, JAPANESE JOURNAL OF RADIOLOGY, 33巻, 10号, pp.627-pp.635, OCT 2015
  179. Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non-B or Non-C Hepatocellular Carcinoma, JOURNAL OF CLINICAL LABORATORY ANALYSIS, 29巻, 6号, pp.480-pp.484, NOV 2015
  180. Sustained virological response to antiviral therapy improves survival rate in patients with recurrent hepatitis C virus infection after liver transplantation, HEPATOLOGY RESEARCH, 45巻, 11号, pp.1047-pp.1054, NOV 2015
  181. Effect of tenofovir disoproxil fumarate on drug-resistant HBV clones, JOURNAL OF INFECTION, 72巻, 1号, pp.91-pp.102, JAN 2016
  182. Elimination of HCV via a non-ISG-mediated mechanism by vaniprevir and BMS-788329 combination therapy in human hepatocyte chimeric mice, VIRUS RESEARCH, 213巻, pp.62-pp.68, FEB 2 2016
  183. Influence of the rs738409 polymorphism in patatin-like phospholipase 3 on the treatment efficacy of non-alcoholic fatty liver disease with type 2 diabetes mellitus, HEPATOLOGY RESEARCH, 46巻, 3号, pp.E146-pp.E153, MAR 2016
  184. The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus, JOURNAL OF GASTROENTEROLOGY, 51巻, 4号, pp.370-pp.379, APR 2016
  185. Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort study, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 31巻, 5号, pp.1009-pp.1015, MAY 2016
  186. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer, NATURE GENETICS, 48巻, 5号, pp.500-pp.+, MAY 2016
  187. Change in Imaging Findings on Angiography-Assisted CT During Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma, CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 39巻, 6号, pp.865-pp.874, JUN 2016
  188. Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease, SCIENTIFIC REPORTS, 6巻, JUL 1 2016
  189. Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization, ANTICANCER RESEARCH, 36巻, 7号, pp.3523-pp.3529, JUL 2016
  190. Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients, HEPATOLOGY RESEARCH, 46巻, 8号, pp.758-pp.764, JUL 2016
  191. Improvement of renal dysfunction in a patient with hepatitis C virus-related liver cirrhosis by daclatasvir and asunaprevir combination therapy: A case report, HEPATOLOGY RESEARCH, 46巻, 9号, pp.944-pp.948, AUG 2016
  192. Three patients treated with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation: Case report, HEPATOLOGY RESEARCH, 46巻, 7号, pp.707-pp.712, JUN 2016
  193. Preoperative Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Prediction of Microvascular Invasion in Small Hepatocellular Carcinoma, JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 40巻, 4号, pp.524-pp.530, JUL-AUG 2016
  194. Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection, JOURNAL OF GASTROENTEROLOGY, 51巻, 11号, pp.1073-pp.1080, NOV 2016
  195. Third-Generation Capsule Endoscopy Outperforms Second-Generation Based on the Detectability of Esophageal Varices, GASTROENTEROLOGY RESEARCH AND PRACTICE, 2016
  196. Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis C, HEPATOLOGY RESEARCH, 46巻, 12号, pp.1256-pp.1263, NOV 2016
  197. Combination therapies with daclatasvir and asunaprevir on NS3-D168 mutated HCV in human hepatocyte chimeric mice, ANTIVIRAL THERAPY, 21巻, 4号, pp.307-pp.315, 2016
  198. Protease Inhibitor Resistance Remains Even After Mutant Strains Become Undetectable by Deep Sequencing, JOURNAL OF INFECTIOUS DISEASES, 214巻, 11号, pp.1687-pp.1694, DEC 1 2016
  199. Whole genome sequencing discriminates hepatocellular carcinoma with intrahepatic metastasis from multi-centric tumors, JOURNAL OF HEPATOLOGY, 66巻, 2号, pp.363-pp.373, FEB 2017
  200. Efficacy and Safety of Daclatasvir Plus Asunaprevir Therapy for Chronic Hepatitis C Patients With Renal Dysfunction, JOURNAL OF MEDICAL VIROLOGY, 89巻, 4号, pp.665-pp.671, APR 2017
  201. Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus, PLOS ONE, 12巻, 3号, MAR 2 2017
  202. Retrograde venography during balloon-occluded retrograde transvenous obliteration of gastric varices, MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 26巻, 1号, pp.1-pp.6, 2017
  203. The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease, JOURNAL OF GASTROENTEROLOGY, 52巻, 2号, pp.253-pp.262, FEB 2017
  204. The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients, JOURNAL OF GASTROENTEROLOGY, 52巻, 3号, pp.366-pp.375, MAR 2017
  205. Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patients, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 32巻, 3号, pp.645-pp.650, MAR 2017
  206. IFNL4 polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis C, HEPATOLOGY RESEARCH, 47巻, 3号, pp.E5-pp.E13, MAR 2017
  207. Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C, JOURNAL OF GASTROENTEROLOGY, 52巻, 4号, pp.504-pp.511, APR 2017
  208. Complete response to short-term sorafenib treatment alone for hepatocellular carcinoma with bone, lymph node, and peritoneum metastases, HEPATOLOGY RESEARCH, 46巻, 13号, pp.1402-pp.1408, DEC 2016
  209. ITPA polymorphism effects on decrease of hemoglobin during sofosbuvir and ribavirin combination treatment for chronic hepatitis C, JOURNAL OF GASTROENTEROLOGY, 52巻, 6号, pp.746-pp.753, JUN 2017
  210. Impact of Hepatitis C Virus Eradication on the Clinical Outcome of Patients with Hepatitis C Virus-Related Advanced Hepatocellular Carcinoma Treated with Sorafenib, ONCOLOGY, 92巻, 6号, pp.335-pp.346, 2017
  211. Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virology, JOURNAL OF GENERAL VIROLOGY, 98巻, 5号, pp.1040-pp.1047, MAY 2017
  212. Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection, HEPATOLOGY RESEARCH, 47巻, 8号, pp.767-pp.772, JUL 2017
  213. Patients with early recurrence of hepatocellular carcinoma have poor prognosis, HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 16巻, 3号, pp.279-pp.288, JUN 2017

社会活動

委員会等委員歴

  1. 学会評議員, 2013年01月, 2013年12月, (財)日本消化器病学会
  2. 肝炎治療費助成対象患者認定審査会委員, 2013年04月, 2015年03月, 広島県
  3. 肝疾患医療連携推進専門委員会委員, 2013年04月, 2014年03月, 広島県地域保健対策協議会
  4. 客員研究員, 2013年05月, 2016年03月, 独立行政法人理化学研究所
  5. 評議員, 2013年04月, 2014年03月, 社団法人 日本肝臓学会